2026-01-15

Swati Patel, Manager, Allpharm discusses with Pharma Industrial India how the company is driving adoption of South Korean pharmaceutical machinery in India through competitive pricing, versatile solutions and robust after-sales service.

Q. Could you introduce us to Allpharm?

Allpharm is a Pune-based company and the exclusive Indian agent for South Korea–based Sejong Pharma Tech. The company supplies pharmaceutical manufacturing equipment, including tablet compression machines, capsule filling machines and coating machines to pharmaceutical manufacturers across India. The company currently serves more than 350 customers nationwide.

Q. What new technology or products are you selling?

We have capsule checkware machine for checking the weight of the capsules for various weights from size 0, 00 and 4. There are different magazines for each capsule size and this is used for checking the weight of the capsules.

Q. How would you differentiate your products and solutions from other competitors?

Our after-sales service is a key differentiator. We provide comprehensive support starting from machine installation, and continue to assist customers with maintenance, breakdowns, and any operational requirements to ensure uninterrupted performance.

Q. How has the demand changed in recent years?

Since last year, there has been strong demand for Sejong’s tablet press machines. The next-generation model is scheduled for launch around April–May next year. In addition, the next-generation capsule checkweigher machinery is also expected to be introduced next year.

Q. How are Indian pharma companies responding to South Korean machinery compared to traditional German equipment?

Compared to other manufacturers—particularly German machinery—the cost of our machines is significantly lower. At the same time, our tablet press machines are versatile and suitable for a wide range of products, which gives us a competitive advantage in this segment.

Q. What about the quality and durability?

The quality is proven and reliable. Many of our customers have been using these machines for 20 to 25 years, and there are already nearly 2,500 machines installed across India.

Q. How has demand increased over the years, particularly when comparing 2004 and 2025?

It is almost increasing.

Q. Do you have a percentage of increase?

It’s 35-50 percent.

Q. Which other markets is Sejong catering to?

We are just the agent for India. They have their machineries all over the world.

Q. Could you share some of the challenges that you face as a distributor in India?

Customer requirements vary from project to project, and we tailor our solutions accordingly to meet their specific needs.

Q. In terms of regulatory compliance, do you have any challenges?

Our machines are fully compliant with 21 CFR requirements and adhere to established pharmaceutical machinery guidelines, ensuring regulatory compliance without any issues.

Q. What is the key USP you highlight when pitching the machine to customers?

After-sales service is what customers value most. Selling the machine is only the first step—without ongoing support and service, the product itself has little value.

Q. What are the common challenges manufacturers bring to you?

For now, there are no challenges. It's all running smoothly.